Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Anuschka Silva-Spínola"'
Autor:
Anuschka Silva-Spínola, Maria João Leitão, Alicia Nadal, Nathalie Le Bastard, Isabel Santana, Inês Baldeiras
Publikováno v:
Alzheimer’s Research & Therapy, Vol 16, Iss 1, Pp 1-10 (2024)
Abstract Background LUMIPULSE G-automated immunoassays represent a widely used method for the quantification of Alzheimer’s disease (AD) biomarkers in the cerebrospinal fluid (CSF). Less invasive blood-based markers confer a promising tool for AD d
Externí odkaz:
https://doaj.org/article/08cc14e4a3274da9960263893dd803c7
Autor:
Maria João Leitão, Anuschka Silva-Spínola, Isabel Santana, Veronica Olmedo, Alicia Nadal, Nathalie Le Bastard, Inês Baldeiras
Publikováno v:
Alzheimer’s Research & Therapy, Vol 11, Iss 1, Pp 1-12 (2019)
Abstract Background Ongoing efforts within the Alzheimer’s disease (AD) field have focused on improving the intra- and inter-laboratory variability for cerebrospinal fluid (CSF) biomarkers. Fully automated assays offer the possibility to eliminate
Externí odkaz:
https://doaj.org/article/f6132cc35b494876b646874cf105fc1b
Publikováno v:
Biomedicines, Vol 10, Iss 2, p 315 (2022)
Dementia remains an extremely prevalent syndrome among older people and represents a major cause of disability and dependency. Alzheimer’s disease (AD) accounts for the majority of dementia cases and stands as the most common neurodegenerative dise
Externí odkaz:
https://doaj.org/article/63dd7e4cb2264835978c72c2f4fc4655
Autor:
Anuschka Silva‐Spínola, Marisa Lima, Maria João Leitão, Catarina Bernardes, João Durães, Diana Duro, Miguel Tábuas‐Pereira, Isabel Santana, Inês Baldeiras
Publikováno v:
European Journal of Neurology. 30:1565-1573
Autor:
Veronica Olmedo, Maria João Leitão, Inês Baldeiras, Isabel Santana, Anuschka Silva-Spínola, Nathalie Le Bastard, Alicia Nadal
Publikováno v:
Alzheimer's Research & Therapy
Alzheimer’s Research & Therapy, Vol 11, Iss 1, Pp 1-12 (2019)
Alzheimer’s Research & Therapy, Vol 11, Iss 1, Pp 1-12 (2019)
Background Ongoing efforts within the Alzheimer’s disease (AD) field have focused on improving the intra- and inter-laboratory variability for cerebrospinal fluid (CSF) biomarkers. Fully automated assays offer the possibility to eliminate sample ma